Verona Pharma shareholders approve $10 billion Merck acquisition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/5/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Verona Pharma shareholders approve $10 billion Merck acquisition
Merck & Co. (NYSE: MRK) Delayed: 150.33 -2.01 (1.32%)
Previous Close $152.34    52 Week High $65.46 
Open $150.83    52 Week Low $47.97 
Day High $152.22    P/E 102.27 
Day Low $150.09    EPS $1.47 
Volume 4,395,788       

(NASDAQ: VRNA) Delayed: 106.91 --0 (-0%)
Previous Close $106.91    52 Week High $ 
Open $106.91    52 Week Low $ 
Day High $106.91    P/E N/A 
Day Low $106.91    EPS $ 
Volume 17,860